Brevan Howard Capital Management’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$178K Buy
2025
Q1
Sell
2024
Q4
$677K Buy
2024
Q3
$300K Buy